Interactions of testosterone and short-photoperiod exposure on the neuroendocrine axis of the male Syrian hamster.
Exposure of adult male golden hamsters to short days (less than 12.5 h light/day) leads to suppression of gonadal function which is secondary to reductions in gonadotropin and prolactin (PRL) secretion. Short-day (SD) exposure also leads to a reduction in hypothalamic norepinephrine (NE) and dopamine (DA) metabolism and an increase in hypothalamic LHRH content which appears to be related to a decrease in LHRH release. To determine whether SD-induced changes in NE and DA metabolism are dependent or independent of changes in circulating testosterone (T) levels and thus possible mediators of photoperiod effects on gonadotropin secretion, the effects of castration and steroid replacement on hypothalamic amine metabolism were studied in male hamsters maintained under long or short photoperiod conditions. The presence of Silastic T-implants resulted in a greater suppression of LH and FSH in SD than in long-day (LD) hamster, but increased median eminence (ME) LHRH content in both groups. Exposure of castrate hamsters to short days led to a reduction of NE turnover in the ME and medial preoptic-suprachiasmatic area (MPOA) and a decrease in serum FSH levels. LH levels tended to be lower, but not significantly so. The decrease in ME NE turnover was potentiated by T replacement, but in the MPOA-SCN, T-implants reversed the effects of short days. NE turnover in the MBH was reduced by T in both LD and SD animals, but the effect was much greater in the SD animals. SD exposure also caused a decrease in ME DA metabolism that was reversed by T replacement.(ABSTRACT TRUNCATED AT 250 WORDS)
D000818:Animals; D002940:Circadian Rhythm / Q000187:drug effects; D006224:Cricetinae; D004298:Dopamine / Q000378:metabolism; D005640:Follicle Stimulating Hormone / Q000097:blood / Q000378:metabolism; D007987:Gonadotropin-Releasing Hormone / Q000097:blood / Q000378:metabolism; D006065:Gonadotropins, Pituitary / Q000097:blood / Q000378:metabolism; D007031:Hypothalamus / Q000187:drug effects* / Q000378:metabolism; D008027:Light; D007986:Luteinizing Hormone / Q000097:blood / Q000378:metabolism; D008297:Male; D008473:Median Eminence / Q000378:metabolism; D008647:Mesocricetus; D009490:Neurosecretory Systems / Q000187:drug effects* / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D009919:Orchiectomy; D009929:Organ Size / Q000187:drug effects; D011301:Preoptic Area / Q000378:metabolism; D012669:Seminal Vesicles / Q000502:physiology; D013493:Suprachiasmatic Nucleus / Q000378:metabolism; D013737:Testis / Q000502:physiology; D013739:Testosterone / Q000494:pharmacology*
D006065:Gonadotropins, Pituitary; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D004298:Dopamine; D009638:Norepinephrine